Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by baystock1on Dec 01, 2018 1:47am

98 Views

Post# 29048789

RE:RE:RE:RE:RE:RE:News Out :) :) :)

Thank you Macer for your helpful response.

We have always known there is "likely" an immune like response to treatment. Now they know the markers involved and the way that it is expressed making it easier to develope and enchance the response by tweaking things a little. It is commical to see the share price and the response from the market for quite some time now. That's what people are missing, the science is bonafide legit.
Macer

baystock1 wrote:So we already knew that Theralases' PDT compounds induce an immune response. It looks like this PR sheds some light on the underlying mechanisms. Or am I missing a more significant revelation ?

Bullboard Posts

Hudbay signs US$300M financing to advance B.C. copper project